Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

NCT00301899 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: pertuzumab
BIOLOGICAL: trastuzumab

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]